These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11092205)

  • 1. Rational therapy in the treatment of systemic sclerosis.
    Furst DE
    Curr Opin Rheumatol; 2000 Nov; 12(6):540-4. PubMed ID: 11092205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the treatment of systemic sclerosis.
    Bournia VK; Vlachoyiannopoulos PG; Selmi C; Moutsopoulos HM; Gershwin ME
    Clin Rev Allergy Immunol; 2009 Jun; 36(2-3):176-200. PubMed ID: 19132559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosis.
    Lin AT; Clements PJ; Furst DE
    Rheum Dis Clin North Am; 2003 May; 29(2):409-26. PubMed ID: 12841302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothesis for the pathogenesis of systemic sclerosis.
    Furst DE; Clements PJ
    J Rheumatol Suppl; 1997 May; 48():53-7. PubMed ID: 9150119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and molecular mechanisms in the pathophysiology of systemic sclerosis.
    Hua-Huy T; Dinh-Xuan AT
    Pathol Biol (Paris); 2015 Apr; 63(2):61-8. PubMed ID: 25818311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sixth international workshop on scleroderma research, Oxford, UK, 30 July--22 August 2000.
    Wollheim FA; Denton CP; Abraham DJ
    Arthritis Res; 2001; 3(1):34-40. PubMed ID: 11269238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast and endothelial apoptosis in systemic sclerosis.
    Jun JB; Kuechle M; Harlan JM; Elkon KB
    Curr Opin Rheumatol; 2003 Nov; 15(6):756-60. PubMed ID: 14569206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?
    Manetti M; Rosa I; Milia AF; Guiducci S; Carmeliet P; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2014 Sep; 73(9):1700-9. PubMed ID: 23852693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic sclerosis: hypothesis-driven treatment strategies.
    Charles C; Clements P; Furst DE
    Lancet; 2006 May; 367(9523):1683-91. PubMed ID: 16714190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological modulation of dermal fibroblasts in scleroderma.
    Perlish JS; Fleischmajer R
    Immunol Ser; 1989; 46():605-24. PubMed ID: 2488871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Sclerosis Pathogenesis and Emerging Therapies, beyond the Fibroblast.
    Sierra-Sepúlveda A; Esquinca-González A; Benavides-Suárez SA; Sordo-Lima DE; Caballero-Islas AE; Cabral-Castañeda AR; Rodríguez-Reyna TS
    Biomed Res Int; 2019; 2019():4569826. PubMed ID: 30809542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathways as novel therapeutic targets in systemic sclerosis.
    Trojanowska M; Varga J
    Curr Opin Rheumatol; 2007 Nov; 19(6):568-73. PubMed ID: 17917537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of dermal connective tissue in scleroderma.
    Kähäri VM
    Ann Med; 1993 Dec; 25(6):511-8. PubMed ID: 8292298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systemic sclerosis: symptomatic treatment].
    Dziankowska-Bartkowiak B; Waszczykowska E; Skretkowicz K
    Pol Merkur Lekarski; 2003 Sep; 15(87):259-62. PubMed ID: 14679853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in pathogenesis and treatment of systemic sclerosis.
    Denton CP
    Clin Med (Lond); 2015 Dec; 15 Suppl 6():s58-63. PubMed ID: 26634684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic factors in systemic sclerosis.
    Mayes MD; Trojanowska M
    Arthritis Res Ther; 2007; 9 Suppl 2(Suppl 2):S5. PubMed ID: 17767743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scleroderma.
    Gilliam AC
    Curr Dir Autoimmun; 2008; 10():258-79. PubMed ID: 18460891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines and human fibrosis.
    LeRoy EC; Trojanowska MI; Smith EA
    Eur Cytokine Netw; 1990; 1(4):215-9. PubMed ID: 1966552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapeutic strategies in scleroderma.
    Denton CP; Black CM
    Curr Rheumatol Rep; 1999 Oct; 1(1):22-7. PubMed ID: 11123010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macro- and microvascular disease in systemic sclerosis.
    Kavian N; Batteux F
    Vascul Pharmacol; 2015 Aug; 71():16-23. PubMed ID: 26044180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.